Indiana · 2025 Regular Session · Bill
HB 1488: Pediatric cancer research and treatment grant.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 1488 is a bill introduced in the Indiana House on January 21, 2025. According to its official title, it concerns: Pediatric cancer research and treatment grant. Primary sponsor: Ryan Lauer (Republican). It lists 1 additional sponsor. Most recent recorded action (January 27, 2025): Representative O'Brien added as coauthor.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Establishes the pediatric cancer research and treatment grant program (grant program) to be administered by the rare disease advisory council (council). Establishes the pediatric cancer research and treatment fund. Sets forth requirements for an entity to receive a grant. Requires the council to develop criteria, policies, procedures, and a plan concerning awarding of the grants. Prioritizes use of the funds to be on innovative research and treatments with the potential of resulting in novel therapies for pediatric cancer. Requires the council to submit an annual report to the governor and legislative council concerning the grant program and publish the report on the Indiana department of health's website.
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Ryan Lauer | Primary sponsor | Republican | House | 59 |
| Tim O'Brien | Co-sponsor | Republican | House | 78 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Representative O'Brien added as coauthor
- First reading: referred to Committee on Public Health
- Authored by Representative Lauer